home / stock / cara / cara quote
Last: | $0.7501 |
---|---|
Change Percent: | 0.65% |
Open: | $0.8 |
Close: | $0.7501 |
High: | $0.8 |
Low: | $0.75 |
Volume: | 251,877 |
Last Trade Date Time: | 05/17/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.7501 | $0.8 | $0.7501 | $0.8 | $0.75 | 251,877 | 05-17-2024 |
$0.8052 | $0.7371 | $0.8052 | $0.87 | $0.7255 | 493,986 | 05-16-2024 |
$0.7599 | $0.7236 | $0.7599 | $0.79 | $0.7013 | 498,578 | 05-15-2024 |
$0.7236 | $0.745 | $0.7236 | $0.7615 | $0.701 | 297,903 | 05-14-2024 |
$0.7503 | $0.7471 | $0.7503 | $0.7744 | $0.72 | 370,555 | 05-13-2024 |
$0.7156 | $0.7575 | $0.7156 | $0.775 | $0.7122 | 194,721 | 05-10-2024 |
$0.7601 | $0.7262 | $0.7601 | $0.779 | $0.725 | 126,795 | 05-09-2024 |
$0.7331 | $0.79 | $0.7331 | $0.8 | $0.71 | 259,306 | 05-08-2024 |
$0.7922 | $0.8091 | $0.7922 | $0.8175 | $0.754101 | 183,296 | 05-07-2024 |
$0.79 | $0.7846 | $0.79 | $0.8315 | $0.77001 | 353,217 | 05-06-2024 |
$0.7782 | $0.7969 | $0.7782 | $0.7969 | $0.7571 | 159,125 | 05-03-2024 |
$0.7722 | $0.7545 | $0.7722 | $0.79 | $0.740994 | 192,965 | 05-02-2024 |
$0.7586 | $0.7559 | $0.7586 | $0.777 | $0.7225 | 190,409 | 05-01-2024 |
$0.7519 | $0.746 | $0.7519 | $0.7875 | $0.721 | 192,151 | 04-30-2024 |
$0.7555 | $0.681 | $0.7555 | $0.7669 | $0.681 | 506,425 | 04-29-2024 |
$0.6843 | $0.69 | $0.6843 | $0.7264 | $0.68 | 169,234 | 04-26-2024 |
$0.7 | $0.661 | $0.7 | $0.7168 | $0.64 | 319,087 | 04-25-2024 |
$0.6716 | $0.7165 | $0.6716 | $0.72 | $0.6613 | 215,512 | 04-24-2024 |
$0.7071 | $0.7187 | $0.7071 | $0.73 | $0.7 | 181,886 | 04-23-2024 |
$0.7304 | $0.66 | $0.7304 | $0.7394 | $0.65 | 346,171 | 04-22-2024 |
News, Short Squeeze, Breakout and More Instantly...
Cara Therapeutics Inc. Company Name:
CARA Stock Symbol:
NASDAQ Market:
Cara Therapeutics Inc. Website:
STAMFORD, Conn., May 06, 2024 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (NASDAQ:CARA), a development-stage biopharmaceutical company leading ...
STAMFORD, Conn., April 02, 2024 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (NASDAQ:CARA), a development-stage biopharmaceutical company leadin...
STAMFORD, Conn., March 07, 2024 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (NASDAQ:CARA), a development-stage biopharmaceutical company leadin...